MedTrace Logo

Carbetocin and Oxytocin in Elective Caesarean Section With High Risk of Postpartum Hemorrhage

NCT02391636 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 264

Last updated 2017-01-25

No results posted yet for this study

Summary

Double blinded randomized controlled study

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

Carbetocin

at delivery of anterior shoulder

DRUG

Oxytocin

at delivery of anterior shoulder

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    collaborator OTHER

  • Ghamra Military Hospital

    lead OTHER

Principal Investigators

  • Maged M El.Sherif · Ghamra Military Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-09-30
Completion
2016-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02391636 on ClinicalTrials.gov